Myasthenia gravis, atypical polyneuropathy and multiple autoimmune phenomena in the same patient, with HLA-immunogenetic profile expectable for Greek chronic inflammatory demyelinating polyneuropathy: a case report

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:2997649 16 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Myasthenia gravis, atypical polyneuropathy and multiple autoimmune phenomena in the same patient, with HLA-immunogenetic profile expectable for Greek chronic inflammatory demyelinating polyneuropathy: a case report
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Purpose: The comorbidity of myasthenia gravis (MG), with other autoimmune disorders like systemic lupus erythematosus (SLE), is relatively frequent but the co-occurrence with chronic inflammatory demyelinating polyneuropathy (CIDP) along with various autoimmune manifestations in the absence of thymoma is of extreme rarity. Our aim is to report a case of a woman who presented the concomitant appearance of MG, axonal sensory-motor polyneuropathy and hepatitis that may indicate an underlying pathogenetic link among the different autoimmune disorders. Materials and methods/results: We present a case of a 54-year-old woman, with a generalized MG and a chronic sensory-motor polyneuropathy, hypothyroidism, anaemia, hepatitis, livedo reticularis and facial flush, of assumed autoimmune background, like SLE, although with persistent negative ANA antibodies, from the beginning and through the whole following years. The Human Leukocyte Antigen (HLA)-DRB1 genotyping showed a profile of alleles (DRB1*11:01/11:04) compatible with CIDP of mainly female gender in Greece and frequencies close to those of Sjogren’s syndrome and scleroderma’s in the Greek population. The diagnostic problems, the atypical clinical, electrophysiological and immunological features are discussed, along with the rarity of the case, with this exceptional combination of autoimmune manifestations, which could be truly associated under the clinical umbrella of a systemic disease, like SLE. However, our patient did not ever fulfil the SLE criteria. Conclusions: To raise awareness among clinicians about the exceptional combination of autoimmune manifestations driven by a specific HLA background. © 2020 Informa UK Limited, trading as Taylor & Francis Group.
Έτος δημοσίευσης:
2020
Συγγραφείς:
Anagnostouli, M.
Vakrakou, A.G.
Zambelis, T.
Boufidou, F.
Nikolaou, C.
Karandreas, N.
Kilidireas, C.
Περιοδικό:
International Journal of Neuroscience
Εκδότης:
Taylor and Francis Ltd.
Επίσημο URL (Εκδότης):
DOI:
10.1080/00207454.2020.1829616
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.